Autres langues Novavax, Inc.

Actions

NVAX

US6700024010

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 07/06/2024			Varia. 5j.	Varia. 1 janv.
18,17 ^USD	-7,08 %		+20,89 %	+278,54 %

07/06	Les vaccins COVID devraient cibler les variantes JN.1 lors de la campagne 2024-25, selon la FDA américaine	RE
06/06	Le S&P 500 et le Nasdaq chutent à la veille de la publication des chiffres de l'emploi aux États-Unis	RE

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

COVID shots should target JN.1 variants in 2024-25 campaign, US FDA says	07/06
S&P 500, Nasdaq dip on the eve of US payrolls data	06/06
Wall Street mixed as Nvidia retreat hits tech stocks; payrolls data in focus	06/06
Novavax Says FDA Review Target Date Set for Covid-19 Vaccine Biologics License Application	06/06
Borsa Usa mista con tech in calo, dati lavoro alimentano speranze taglio tassi	06/06
Novavax Prepared to Deliver JN.1 Protein-based Non-mRNA COVID-19 Vaccine This Fall Consistent with U.S. FDA VRBPAC Recommendation	06/06
Peraso Inc. (NASDAQ: PRSO) Announces Paradigm-Shifting mmWave Wi-Fi Advancements with Phased Array Antenna Technology	06/06
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines	06/06
Novavax Says It Can Deliver Recommended Covid Vaccine in September	05/06
Novavax : Prepared to Deliver JN.1 Protein based Non mRNA COVID 19 Vaccine This Fall Consistent with U.S. FDA VRBPAC Recommendation	05/06
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say	05/06
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says	03/06
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns	30/05
Novavax to Participate in 2024 Jefferies Global Healthcare Conference	30/05
Sanofi and Novavax Announce Co-Exclusive Licensing Agreement to Co-Commercialize Covid-19 Vaccine and Develop Novel Flu-Covid-19 Combination Vaccines	28/05
Novavax awaits FDA decision on whether its next COVID shot can be offered in US	24/05
Novavax, Inc. Notifies Retirement of Filip Dubovsky as President, Research and Development, Effective as of June 30, 2024	23/05
Novavax : 1ère expédition du vaccin antipaludique R21/MatrixM	21/05
Serum Institute of India Ships Its First Set of R21/Matrix-M? Malaria Vaccine Doses to Africa [press release]	20/05
Global markets live: Apple, Tesla, Pfizer, AstraZeneca, Microsoft...	20/05

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Novavax bondit suite à l'accord de 1,2 milliard de dollars avec Sanofi pour un vaccin

Le 10 mai 2024 à 20:52